Navigation Links
Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines
Date:6/13/2008

CHAPEL HILL, N.C., June 13 /PRNewswire/ -- Best Practices, LLC's latest benchmarking study explains how U.S. pharmaceutical and biotechnology organizations can optimize their CI operations while working within defined guidelines.

Particular attention is paid to CI information sources, what is being collected, and how CI groups work within legal groups to develop standard operating procedures for data collection that are in the best interests of the organization as a whole and to maximize the CI department's ability to deliver results.

Savvy CI leaders employ multiple, even overlapping, secondary data sources and triangulate from them to develop the most accurate information and projections, described in the newly published study, "Pharmaceutical Competitive Intelligence Excellence: Optimizing Data Collection with Approved Guidelines" by Best Practices, LLC. Click here for complimentary download: http://www3.best-in-class.com/dr316.htm

Executives from many of the top 50 pharmaceutical companies have found that one of the most useful tools that they have at their disposal when it comes to gaining information and benchmarking best practices about competitive intelligence is the Best Practices Database. To view a list of just some of the documents pertaining to competitive intelligence click on this link: http://www3.best-in-class.com/dr316.htm

Best Practices Database covers many key functionality areas pertaining to Pharma Industry such as:
-- Resources and strategies required to gain crucial market access

-- Creating blockbusters in an increasingly competitive marketplace

-- Publications strategies that give credibility and increase reputation

-- Key to building effective brand teams

-- Case studies for successful re-launches

-- Strategies for successful structure and roles in launch processes

Top 3 reasons identified by Best Practices, LLC to sign-up for a database tours are:
1. Gather industry-specific Competitive Intelligence

2. Learn Best Practices and use them for yours and your company's growth

3. Gather information to train your staff for proficiency and efficiency

To have a better understanding of Best Practices Database, sign-up for a complimentary tour by clicking here: http://www3.best-in-class.com/dw212.htm

For more information on Best Practices, LLC's products and services please contact Robert Naylor, Senior Research Analyst, Best Practices, LLC at 919-767-9244 or rnaylor@best-in-class.com

ABOUT BEST PRACTICES, LLC

Best Practices, LLC, conducts work based on the simple yet profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies. Specializing in best-in-class benchmarking research, Best Practices, LLC probes critical issues that drive organizational impact, influence and efficiency. From facilitating peer-to-peer networking and conducting customized benchmarking research to providing on-demand best practices, Best Practices, LLC offers solutions for all your benchmarking needs.


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)...   Sienna Biopharmaceuticals, Inc. , a privately held, ... Richard Peterson will join the company as ... who brings more than two decades of global financial ... retiring at the end of April but will continue ... Sienna from Novan, Inc., where he served as Chief ...
(Date:3/23/2017)... ... 2017 , ... AxioMed president, Jake Lubinski, describes the AxioMed ... deformed, which is identical to how the human discs work to distribute force. ... to its natural state along a hysteresis curve, exactly like a healthy human ...
(Date:3/23/2017)... DUBLIN , Mar 23, 2017 ... "Biorefinery Products: Global Markets" report to their offering. ... The ... from $466.6 Billion in 2016 at a CAGR of 8.9%, ... of energetic and non-energetic bioproducts into seven major product segments: ...
(Date:3/23/2017)... March 23, 2017  SeraCare Life Sciences, ... in vitro diagnostics manufacturers and clinical laboratories, ... first multiplexed Inherited Cancer reference material ... by next-generation sequencing (NGS). The Seraseq™ Inherited Cancer ... input from industry experts to validate the ...
Breaking Biology Technology:
(Date:3/6/2017)... 6, 2017 Mintigo , the ... announced Predictive Sales Coach TM , its new ... intelligence into Salesforce. This unique AI application will ... organizations with deep knowledge of their customers and ... engagement. Predictive Sales Coach extends Mintigo,s existing customer ...
(Date:3/2/2017)... -- Australian stem cell and regenerative medicine company, ... agreement with the Monash Lung Biology Network, a consortia ... Department of Pharmacology at Monash University, Melbourne ... support the use of Cymerus™ mesenchymal stem cells (MSCs) ... is a chronic, long term lung condition recognised by ...
(Date:2/28/2017)...  EyeLock LLC, ein marktführendes Unternehmen im Bereich ... Lösung zur Iris-Erkennung auf der neuesten Mobilplattform ... dem Mobile World Congress 2017 (27. Februar ... 3, Stand 3E10, vorstellen. Der ... – eine Kombination aus Hardware, Software und ...
Breaking Biology News(10 mins):